lovenox News
Most Popular lovenox Story
Watson, Amphastar launch Lovenox copy on court ruling
Momenta Pharmaceuticals ($MNTA) has lost its exclusive hold on the generic Lovenox market--at least temporarily. Amphastar, which has been developing its own version of the Sanofi ($SNY) Read more...
Latest Headlines
- January 26, 2012
- December 2, 2011
- November 14, 2011
- October 31, 2011
- September 20, 2011
- May 25, 2011
- January 26, 2011
- December 3, 2010
- November 9, 2010
- October 26, 2010
- October 22, 2010
- August 26, 2010
- August 5, 2010
- July 26, 2010
- January 27, 2010
- August 12, 2009
- April 27, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
